Tempsens Instruments shares surge 17%; stock rallies whopping 89% from IPO price in just over 2 months | Key triggers LiveMint · Markets 4m ago
UBS reiterates Buy on Protagonist Therapeutics stock citing Mimrylo launch progress Investing.com · News 12m ago
UBS raises Iovanace Biotherapeutics price target to $8 on revenue outlook Investing.com · News 12m ago
UBS raises IDEXX Laboratories stock price target on strong international growth Investing.com · News 18m ago
Piper Sandler raises Palantir stock price target to $235 on revenue growth Investing.com · News 18m ago
Wells Fargo cuts Cipher Mining stock price target on campus delivery timeline Investing.com · News 18m ago